1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South & Central America Coagulation Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South & Central America Coagulation Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South & Central America Coagulation Market Regional Analysis
6.2 South & Central America Coagulation Market Revenue 2020-2030 (US$ Million)
6.3 South & Central America Coagulation Market Forecast Analysis
7. South & Central America Coagulation Market Analysis – by Disease Indications
7.1 Vitamin K Deficiency
- 7.1.1 Overview
- 7.1.2 Vitamin K Deficiency: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Liver Disease
- 7.2.1 Overview
- 7.2.2 Liver Disease: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Disseminated Intravascular Coagulation & Pulmonary Embolism
- 7.3.1 Overview
- 7.3.2 Disseminated Intravascular Coagulation & Pulmonary Embolism: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Development of Circulating Anticoagulants
- 7.4.1 Overview
- 7.4.2 Development of Circulating Anticoagulants: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Hemophilia
- 7.5.1 Overview
- 7.5.2 Hemophilia: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.6 Von Willebrand\'s Disease
- 7.6.1 Overview
- 7.6.2 Von Willebrand\'s Disease: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. South & Central America Coagulation Market Analysis – by Type
8.1 Clinical Laboratory Analyzers
- 8.1.1 Overview
- 8.1.2 Clinical Laboratory Analyzers: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Point-of-Care Testing Analyzers
- 8.2.1 Overview
- 8.2.2 Point-of-Care Testing Analyzers: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. South & Central America Coagulation Market Analysis – by Offering
9.1 Prothrombin Time Testing
- 9.1.1 Overview
- 9.1.2 Prothrombin Time Testing: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Fibrinogen Testing
- 9.2.1 Overview
- 9.2.2 Fibrinogen Testing: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Activated Clotting Time Testing
- 9.3.1 Overview
- 9.3.2 Activated Clotting Time Testing: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Activated Partial Thromboplastin Time Testing
- 9.4.1 Overview
- 9.4.2 Activated Partial Thromboplastin Time Testing: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 D-Dimmer Testing
- 9.5.1 Overview
- 9.5.2 D-Dimmer Testing: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Platelets Function Testing
- 9.6.1 Overview
- 9.6.2 Platelets Function Testing: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. South & Central America Coagulation Market Analysis – by Treatment
10.1 Anti-Fibrinolytic Drugs
- 10.1.1 Overview
- 10.1.2 Anti-Fibrinolytic Drugs: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Birth Control Pills
- 10.2.1 Overview
- 10.2.2 Birth Control Pills: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Desmopressin & Immunosuppressive Medicines
- 10.3.1 Overview
- 10.3.2 Desmopressin & Immunosuppressive Medicines: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.4 Vitamin K Supplements
- 10.4.1 Overview
- 10.4.2 Vitamin K Supplements: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.5 Blood Thinners
- 10.5.1 Overview
- 10.5.2 Blood Thinners: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.6 Thrombin Inhibitors or Thrombolytics
- 10.6.1 Overview
- 10.6.2 Thrombin Inhibitors or Thrombolytics: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.7 Replacement Therapy
- 10.7.1 Overview
- 10.7.2 Replacement Therapy: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.8 Catheter-Assisted Thrombus Removal
- 10.8.1 Overview
- 10.8.2 Catheter-Assisted Thrombus Removal: South & Central America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. South & Central America Coagulation Market – South and Central America Analysis
11.1 Overview
11.2 South and Central America
- 11.2.1 South & Central America Coagulation Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 South & Central America Coagulation Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 Brazil:
South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 Brazil: South & Central America Coagulation Market Breakdown, by Disease Indications
- 11.2.1.1.2 Brazil: South & Central America Coagulation Market Breakdown, by Type
- 11.2.1.1.3 Brazil: South & Central America Coagulation Market Breakdown, by Offering
- 11.2.1.1.4 Brazil: South & Central America Coagulation Market Breakdown, by Treatment
- 11.2.1.2 Argentina:
South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Argentina: South & Central America Coagulation Market Breakdown, by Disease Indications
- 11.2.1.2.2 Argentina: South & Central America Coagulation Market Breakdown, by Type
- 11.2.1.2.3 Argentina: South & Central America Coagulation Market Breakdown, by Offering
- 11.2.1.2.4 Argentina: South & Central America Coagulation Market Breakdown, by Treatment
- 11.2.1.3 Rest of South and Central America :
South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 Rest of South and Central America : South & Central America Coagulation Market Breakdown, by Disease Indications
- 11.2.1.3.2 Rest of South and Central America : South & Central America Coagulation Market Breakdown, by Type
- 11.2.1.3.3 Rest of South and Central America : South & Central America Coagulation Market Breakdown, by Offering
- 11.2.1.3.4 Rest of South and Central America : South & Central America Coagulation Market Breakdown, by Treatment
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Genrui Biotech Co., Ltd
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Horiba Ltd.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 ImproGen Diagnostik Kimya San. & Tic. Ltd.ti
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Siemens Healthineers AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Sysmex Corp
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Transasia Bio-Medicals Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations